Activity

UCD
Urea Cycle Disorders
HCC
Liver Cancer
CKD
Chronic Kidney Disease

UCD Ph2

2022

UCD Ph2
ALF
NASH
NASH
AKI

2023

2024

IMPD Approved, IlT

2025

Clinical Program ongoing; EMA Scientific Advice completed

2026